BioSpace News Archive

BioMidwest

Align Technology Announces $75 Million Accelerated Stock Repurchase Program

Align Technology, Inc. announced that it has entered into a new accelerated stock repurchase agreement with Goldman Sachs & Co LLC, to repurchase $75 million of Align’s common stock under Align’s $1.0 billion stock repurchase program announced on May 13, 2021.

August 2, 2021
·
3 min read
Business

Evoke Pharma and EVERSANA Announce Support of The International Foundation for Gastrointestinal Disorders’ (IFFGD) August Gastroparesis Awareness Month

Evoke Pharma and EVERSANA ™ , today announced support of the International Foundation for Gastrointestinal Disorders (IFFGD) August Gastroparesis Awareness Month and sponsorship for the upcoming Digestive Health Virtual Walk in honor of the organization’s 30th anniversary.

August 2, 2021
·
9 min read
Biotech Bay

89bio Completed Target Enrollment in Histology Cohort to Evaluate BIO89-100 for the Treatment of NASH- Study

89bio, Inc. today announced that it has completed target enrollment of 20 patients in the paired-biopsy, open-label histology cohort in biopsy-confirmed fibrosis stage F2 – F3 NASH patients.

August 2, 2021
·
3 min read
RealView Imaging Ltd., World Leader in Medical Holography, Receives FDA Clearance for its Groundbreaking HOLOSCOPE™-i Holographic System

RealView Imaging Ltd. today announced that it has received FDA 510(k) clearance for its HOLOSCOPE™-i holographic system. The system creates spatially accurate, three-dimensional interactive medical holograms, based on data received from standard CT scans and 3D ultrasound systems.

August 2, 2021
·
4 min read
Business

Atara Biotherapeutics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021

Atara Biotherapeutics, Inc. today announced the Company will release second quarter 2021 financial results after market close on Monday, August 9, 2021.

August 2, 2021
·
2 min read
Business

Fabrinet to Announce Fourth Quarter and Fiscal-Year 2021 Financial Results on August 16, 2021

Fabrinet today announced it will release its fourth quarter and fiscal-year 2021 financial results for the period ended June 25, 2021 after market close on Monday, August 16, 2021.

August 2, 2021
·
1 min read
FDA

Autobahn Therapeutics Announces Orphan Drug Designation Granted to ABX-002 for the Treatment of X-linked Adrenoleukodystrophy

Autobahn Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for the company’s investigational product candidate, ABX-002, for the treatment of patients with X-linked adrenoleukodystrophy.

August 2, 2021
·
2 min read
Procaps Group to Host Virtual Investor and Analyst Day on Thursday, August 19, 2021 at 10:00 a.m. Eastern Time

Procaps to Introduce Senior Leadership Team, Review Reported Second Quarter 2021 Financial Results and Full Year 2021 Guidance with Analysts and Investors

August 2, 2021
·
10 min read
Business

Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

Sema4 today announced it will release financial results for the second quarter of 2021 after the market close on Monday, August 16, 2021.

August 2, 2021
·
1 min read
Biotech Bay

Medicines360, MSI Reproductive Choices and MSK Announce Launch of Avibela® Hormonal Intrauterine Device in Kenya

Medicines360, MSI Reproductive Choices (MSI) and Marie Stopes Kenya (MSK) today announced the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Kenya.

August 2, 2021
·
8 min read